A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents

scientific article published on 24 January 2008

A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10856-008-3378-5
P698PubMed publication ID18214645
P5875ResearchGate publication ID5636380

P50authorRui L. ReisQ26856925
Alexandra P. MarquesQ41537020
Helena S. AzevedoQ41877121
Elizabeth R BalmayorQ42741551
P2093author name stringKadriye Tuzlakoglu
P2860cites workPorous starch-based drug delivery systems processed by a microwave routeQ30674923
Materials for protein delivery in tissue engineeringQ33933279
Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applicationsQ34625727
Materials in particulate form for tissue engineering. 1. Basic concepts.Q37014322
Materials in particulate form for tissue engineering. 2. Applications in boneQ37014341
Novel starch-based scaffolds for bone tissue engineering: cytotoxicity, cell culture, and protein expression.Q40507774
The biocompatibility of novel starch-based polymers and composites: in vitro studiesQ40752643
Biocompatibility testing of novel starch-based materials with potential application in orthopaedic surgery: a preliminary studyQ40796308
Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch‐based three‐dimensional scaffoldsQ44601486
In Vitro Assessment of the Enzymatic Degradation of Several Starch Based BiomaterialsQ44648195
Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix depositionQ46317560
Entrapment ability and release profile of corticosteroids from starch-based microparticlesQ46371669
Functional magnetic particles for medical application.Q51335772
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteinsQ73594301
Measurement of cellulase activitiesQ121678549
P433issue4
P921main subjectbiodegradationQ696715
drug deliveryQ1392806
tissue engineeringQ1540285
P304page(s)1617-1623
P577publication date2008-01-24
P1433published inJournal of Materials Science: Materials in MedicineQ6295496
P1476titleA novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents
P478volume19

Reverse relations

cites work (P2860)
Q28817570Hybrid polyurea elastomers with enzymatic degradation and tunable mechanical properties
Q57171138In vitro degradation and in vivo biocompatibility of chitosan–poly(butylene succinate) fiber mesh scaffolds
Q46876149On the use of dexamethasone-loaded liposomes to induce the osteogenic differentiation of human mesenchymal stem cells
Q39132465Poly(lactide-co-glycolide acid)/biphasic calcium phosphate composite coating on a porous scaffold to deliver simvastatin for bone tissue engineering.
Q44317847Preparation and characterization of novel poly(ε-caprolactone)/biphasic calcium phosphate hybrid composite microspheres.
Q38947338Preparation, Characterization and Evaluation of Drug Release Properties of Simvastatin-loaded PLGA Microspheres
Q33596408Solving cell infiltration limitations of electrospun nanofiber meshes for tissue engineering applications
Q39832845Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2
Q36974665The pharmacology of regenerative medicine
Q57383078Water Soluble Polymers for Pharmaceutical Applications

Search more.